Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2000-07-03
2010-02-02
Huynh, Phuong (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S130100, C424S139100, C424S141100, C424S145100
Reexamination Certificate
active
07655227
ABSTRACT:
The present invention provides an agent for ameliorating low vasopressin level, which comprises, as an active ingredient, a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor thereof; and an agent for ameliorating a symptom caused by a decrease in vasopressin level, which comprises, as an active ingredient, a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor thereof.
REFERENCES:
patent: 4771124 (1988-09-01), Rosenblatt et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5001223 (1991-03-01), Rosenblatt et al.
patent: 5217896 (1993-06-01), Kramer et al.
patent: 5626845 (1997-05-01), Yoneda et al.
patent: 5849695 (1998-12-01), Cohen et al.
patent: 5993817 (1999-11-01), Yoneda et al.
patent: 6180370 (2001-01-01), Queen et al.
patent: 6903194 (2005-06-01), Sato et al.
patent: 2266332 (1998-04-01), None
patent: 0 293 130 (1988-11-01), None
patent: 0293 158 (1988-11-01), None
patent: 0 449 405 (1991-10-01), None
patent: 0 811 383 (1997-12-01), None
patent: 0 878 201 (1998-11-01), None
patent: 0 962 467 (1999-12-01), None
patent: 1 004 313 (2000-05-01), None
patent: 1 090 643 (2001-04-01), None
patent: 2-207099 (1990-08-01), None
patent: 4-502408 (1992-05-01), None
patent: 4-228089 (1992-08-01), None
patent: 7-165790 (1995-06-01), None
patent: 7-316195 (1995-12-01), None
patent: 11-80025 (1999-03-01), None
patent: 11-222440 (1999-08-01), None
patent: 2000-080100 (2000-03-01), None
patent: WO 89/11297 (1989-11-01), None
patent: WO 89/11298 (1989-11-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 91/16928 (1991-11-01), None
patent: WO 92/00753 (1992-01-01), None
patent: WO 92/17602 (1992-10-01), None
patent: WO 93/13133 (1993-07-01), None
patent: WO 94/11523 (1994-05-01), None
patent: WO 96/03437 (1996-02-01), None
patent: WO 96/39184 (1996-02-01), None
patent: WO 96/22790 (1996-08-01), None
patent: WO 96/26737 (1996-09-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 98/13388 (1998-04-01), None
patent: WO 98/51329 (1998-11-01), None
patent: WO 99/57139 (1999-11-01), None
patent: WO 00/00219 (2000-01-01), None
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Kuby et al., 1994, Immunology, second edition, pp. 85-96.
Abaza et al, J of Protein Chemistry 11(5): 433-444, 1992.
Harlow et al, in Antibodies a Laboratory Manual, 1988, Cold Spring harbor laboratory publication, Cold Spring Harobr, NY, pp. 626-629.
Hotta et al, Endocr J 45(6): 773-8, Dec. 1998.
Kitamura et al, Biochem Biophys Res Commun 171(3): 1387-94, Sep. 1990.
Banerjiee et al, J Immunology 169: 5137-5144, 2002.
Rudikoff et al, Proc Natl Acad Sci USA 1982 vol. 79 p. 1979.
Wu et al. J. Mol. Biol. 294: 151-162, 1999.
Kobrin et al, J Immunology 146: 2017-2020, 1991.
Barrios et al, J Molecular Recognition 17: 332-338, 2004.
Caldwell et al, Progress in Neurobiology 84: 1-24, 2008.
U.S. Appl. No. 09/269,332, filed Mar. 25, 1999, Sato et al.
Etsuro Ogata, M.D., Ph. D., “Parathyroid Hormone-Related Protein as a Potential Target of Therapy for Cancer-Associated Morbidity”, Cancer Supplement vol. 88, No. 12, pp. 2909-2911. Jun. 15, 2000.
U.S. Appl. No. 09/423,800, filed Nov. 12, 1999, Sato et al.
U.S. Appl. No. 09/720,326, filed Dec. 22, 2000, Sato et al.
Abou-Samra et al., Expression Cloning of a Common Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide from Rat Osteoblast-Like Cells: A Single Receptor Stimulates Intracellular Accumulation of Both cAMP and Inositol Trisphosphates and Increases Intracellular Free Calcium,Proceedings of the National Academy of Sciences,89:2732-2736 (1992).
Baba, PTH/PTHrP,Clinical Calcium,5:97-101 (1995) (English Translation).
Beck, et al., Lipolytic Factors Associated with Murine and Human Cancer Cachexia,Journal of the National Cancer Institute,82:1922-1926 (1990).
Belyavsky et al., PCR-Based cDNA Library Construction: General cDNA Libraries at the Level of a Few Cells,Nucleic Acids Research,17:2919-2933 (1989).
Burtis, Parathyroid Hormone-Related Protein: Structure, Function, and Measurement,Clinical Chemistry,38:2171-2183 (1992).
Carter et al., Humanization of an Anti-p185HER2Antibody for Human Cancer Therapy,Proceedings of the National Academy of Sciences,89:4285-4289 (1992).
Chirgwin et al., Isolation of Biologically Active Ribonucleic Acid From Sources Enriched in Ribonuclease,Biochemistry,18:5294-5299 (1979).
Chomczynski et al., Single-Step Method of RNA Isolation By Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction,Analytical Biochemistry,162:156-159 (1987).
Chothia, Canonical Structures for the Hypervariable Regions of Immunoglobulins,Journal Molecular Biology,196:901-917 (1987).
Co et al., Chimeric and Humanized Antibodies with Specificity for the CD33 Antigen,The Journal of Immunology,148:1149-1154 (1992).
Co et al., Humanized Antibodies for Antiviral Therapy,Proceedings of the National Academy of Sciences,88:2869-2873 (1991).
Coleman et al., Biochemical Mechanisms of Parathyroid Hormone Action,The Parathyroids, Basic and Clinical Concepts,239-258 (1994). Chapter 16, Raven Press NY.
Cuisinier et al., Mechanisms That Generate Human Immunoglobulin Diversity Operate From the 8thWeek of Gestation in Fetal Liver,European Journal of Immunology,23:110-118 (1993).
Dariavach et al., Human Immunoglobulin Cλ6 Gene Encodes the Kern+Oz λ Chain and Cλ4 andCλ5 are Pseudogenes,Proceedings of the National Academy of Sciences,84:9074-9078 (1987).
Deftos et al., Utilization of a Potentially Universal Downstream Primer in the Rapid Identification and Characterization of Vλ Genes From Two New Human Vλ Families,Scandinavian Journal of Immunology,39:95-103 (1994).
de St. Groth, et al., Production of Monoclonal Antibodies: Strategy and Tactics,Journal of Immunological Methods,35:1-21 (1980).
Dworkin et al., Dietary Intake in Patients with Acquired Immunodeficiency Syndrome (AIDS), Patients with AIDS-Related Complex, and Serologically Positive Human Immunodeficiency Virus Patients: Correlations with Nutritional Status,Journal of Parenteral and Enteral Nutrition,14:605-609 (1990).
Farmer et al., Speculations on the Design of Nonpeptidic Peptidomimetics,TIPS,4:362-365, (1982).
Frohman et al., Rapid Production of Full-Length cDNAs From Rare Transcripts: Amplification Using a Single Gene-Specific Oligonucleotide Primer,Proceedings of the National Academy of Sciences,85:8998-9002 (1998).
Galfrè et al., Rat × Rat Hybrid Myelomas and A Monoclonal Anti-Fd Portion of Mouse IgG,Nature,277:131-133 (1979).
Gorman et al., Reshaping a Therapeutic CD4 Antibody,Proceedings of the National Academy of Sciences,88:4181-4185 (1991).
Hammond et al., Respiratory Muscle Strength in Congestive Heart Failure,Chest,98:1091-1094 (1990).
Hardman et al.,Goodman&Gilman's The Pharmacological Basis of Therapeutics,9thed., McGraw-Hill Co. (USA), pp. 1528-1529 (1995).
Hardman et al.,Goodman&Gilman's The Pharmacological Basis of Therapeutics,9thed., McGraw-Hill Co. (USA), pp. 1523-1524 (1995).
Hardman et al.,Goodman&Gilman's The Pharmacological Basis of Therapeutics,8thed., McGraw-Hill Co. (USA), pp. 3-32 (1990).
Harris et al., Therapeutic Antibodies—The Coming of Age,TIBTECH,11:42-44 (1993).
Ikeda, Molecular Biology of Parathyroid Hormone-Related Peptide,Nihon Rinshou,53:37-45 (1995) (English Abstract).
Ikeda, Development of Novel Endocrinotherapy Targeting Cancer and Paraneoplastic Syndromes,Progress in Clinical Pharmacology,16:155-161 (1995) (English Abstract).
Jones et al., Rapid PCR-Cloning of Full-Length Mouse Immunoglobulin Variable Regions,Bio/Technology,9:88-89 (1991).
Jüppner et al., A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide,Science,254:1024-1026 (1991).
Kaji et al., Role of Dual Signal Transduction Systems in the Stimulation of Bone Resorption by Parathyroid Hormone-Related Peptide, The Direc
Azuma Yumiko
Ogata Etsuro
Onuma Etsuro
Saito Hidemi
Tsunenari Toshiaki
Chugai Seiyaku Kabushiki Kaisha
Huynh Phuong
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Agents for ameliorating low vasopressin level does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agents for ameliorating low vasopressin level, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for ameliorating low vasopressin level will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4226437